Catch up with our latest volumes and outcomes data
Targeted IL-1 blockers and CMR techniques allow more-tailored treatment strategies
Phase 3 study may lead to first FDA approval for the indication
An ultra-practical update on current care strategies and emerging therapies
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Incremental prognostic value demonstrated for the first time
Why a new paper is a must read for those managing the condition
Using an imaging-guided approach